Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

Document and Entity Information - shares
9 Months Ended
Jun. 30, 2019
Aug. 07, 2019
Document and Entity Information [Abstract]    
Entity Registrant Name Citius Pharmaceuticals, Inc.  
Entity Central Index Key 0001506251  
Amendment Flag false  
Current Fiscal Year End Date --09-30  
Document Type 10-Q  
Document Period End Date Jun. 30, 2019  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2019  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Shell Company false  
Entity Emerging Growth Company false  
Entity Ex Transition Period false  
Entity Common Stock, Shares Outstanding   22,075,781
Entity File Number 001-38174  
Entity Interactive Data Current Yes  
Entity Incorporation State Country Code NV